IC13.3, ic16 RA Flashcards

1
Q

What are the cytokines involved in RA

A

TNF, IL1, IL6, IL17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathology of RA

A

Macrophage secretes TNF
TNF is the most important cytokine in inflammation, stimulate synovial fibroblast to secrete other cytokines and MMP (Matrix Metalloproteinase)
MMP and Neutrophils will break down cartilage, cause bone destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of RA (7 points)

A

Pain
Swelling
Redness, warmth
Early morning stiffness > 30 mins
Systemic symptoms eg. General aching, Fatigue, Fever, Weight loss, Depression
Deformities eg. swan neck, boutonniere
Loss of function, ability to carry out ADL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 types of lab findings for RA

A

Autoantibodies tests
Rheumatoid factor (RF): +ve
Anti-CCP assay: +ve
Patients may have either, so need do both

Acute phase response
Erythrocyte sedimentation rate (ESR): High
C-reactive protein (CRP): High

FBC
Hematocrit: Low
Platelets, WBC: High

X-ray
Not used for diagnosis
Monitor disease progression, late in course of disease
Monitor for narrowing joint space, erosion around margin of joint, hypertrophic synovial tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How to diagnose RA

A

At least 6 points in the American College of Rheumatology test
At least 6 weeks duration of symptoms
Joint involvement (single or multiple)
Acute phase reactants CRP, ESR
+ve RF or Anti-CCP test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Criteria for remission

A

6 months
At most 1 joint swollen or tender
CRP ≤ 1mg/dL (low inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the types of drugs used in RA

A

To reduce inflammation
NSAIDs (used before RA is diagnosed)
Glucocorticoids

Maintenance therapy
csDMARDs (Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide)
bDMARD (TNFa inhibitor, IL6 receptor antagonist, CD20)
tsDMARD (JAK inhibitor Tofa, Bari)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Principle for glucocorticoid use

what is the max duration

A

Given to bridge DMARD therapy, prescribed together
Eg. Prednisolone ≤ 7.5mg / day
Used for shortest duration possible

Max duration is 3 months, Taper and discontinue
Discontinue when b/tsDMARD started

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Side effects of glucocorticoids

A

Osteoporosis / osteonecrosis
Insulin resistance
Gastric ulcer
Cataract, glaucoma
Increased CVD risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

For low disease activity, what DMARD to use?

Moderate - severe disease activity?

A

Low: Hydroxychloroquine or Sulfasalazine preferred

Mod - Severe: MTX monotherapy + short term glucocorticoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the starting dose of Methotrexate

Target dose

A

7.5mg once a week
Give folic acid 5mg once a week, the next day

Target: 15mg a week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the MOA of Methotrexate

A

1) (major) Increase adenosine levels via ATIC inhibition
ATIC inhibition → Increased adenosine act on adenosine receptors
Immune response: Stop T cells production, inhibition of macrophage function
Anti-inflammatory: Decrease in pro-inflammatory cytokines

2) (minor) Inhibit dihydrofolate reductase → resulting in side effects
Inhibit DNA methylation, synthesis of DNA bases (Purine - AG, Pyrimidine - CUT), essential amino acid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of MTX (7 points)

A

Nausea, vomiting
Mouth, GI ulcers
Hair thinning
Liver: increased transaminases, cirrhosis
Myelosuppression
Photosensitivity (protect from light)
SJS / TEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Contraindication of MTX

A

Pre-existing liver disease
Immunodeficiency
Blood dyscrasia
Pregnancy (teratogenic)
Avoid in CrCl < 30ml/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monitoring of MTX

A

FBC
LFT (AST, ALT, Albumin, Bilirubin)
SCr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is folic acid needed with MTX

A

Folate enters cells, converted to Dihydrofolate by Dihydrofolate reductase → Tetrahydrofolate → eventually produce DNA bases and amino acids

Methotrexate inhibit Dihydrofolate reductase, cause nausea, hairloss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Folic acid vs Folinic acid

A

Folic acid / Folate
Cheaper, but need higher doses

Folinic acid
Expensive, but more efficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA of Sulfasalazine

Starting dose of Sulfasalazine

A

Metabolised to Sulfapyridine (active) and 5-aminosalicylic acid (5 ASA)

suppress T cell, B cell, macrophages
Decrease inflammatory cytokines IL1, 6, TNF

500mg 1-2x a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Side effects of Sulfasalazine (7 points)

A

Nausea, vomiting
Headache, dizziness
Rash
G6PD Haemolytic anaemia
Neutropenia
Reversible infertility in men (Oligospermia)
Urine discolouration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which csDMARD does not have hair loss / alopecia as side effect

A

Sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Contraindication of Sulfasalazine

A

Sulfonamide allergy
G6PD Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which is the safest csDMARD for pregnancy

A

Sulfasalazine

23
Q

Dose of hydroxychloroquine

A

200-400mg a day

24
Q

Contraindication with hydroxychloroquine

A

Pre-existing retinopathy
G6PD deficiency

25
Which drugs are contraindicated in G6PD deficiency
Sulfasalazine Hydroxychloroquine
26
What is the MOA of Hydroxychoroquine (3 points)
Reduce MHC class 2 expression and antigen presentation Reduced TNF, IL1, cartilage resorption Antioxidant activity
27
Side effect of hydroxychloroquine
Nausea, vomiting Stomach pain Dizziness Hair loss Ocular toxicity (retinopathy) Photosensitivity, hyperpigmentation QT prolongation
28
Monitoring for hydroxychloroquine
eye exam
29
Indication of Hydroxychloroquine
Least potent, Best tolerated
30
Which medication dont need to monitor FBC
Hydroxychloroquine the rest need to monitor
31
Leflunomide dose
Loading dose: 100mg a day for 3 days Maintenance: 20mg a day
32
MOA of Leflunomide
Converted to active metabolite Teriflunomide Decrease pyrimidine synthesis Inhibit T cell proliferation and B cell autoantibody production
33
Which drugs decrease pyrimidine synthesis
Methotrexate and leflunomide
34
Contraindications of Leflunomide (4 points)
ALT > 2x ULN: avoid use Preexisting liver disease Immunodeficiency Pregnancy
35
PK of Leflunomide
Has long half life (years after last dose) Use Cholestyramine (bile salt binding resin) to remove Leflunomide
36
Side effect of Leflunomide
Diarrhea Increase transaminases Alopecia (hair loss) Weight gain Myelosuppression (bone marrow suppression) Teratogenic
37
similarities between mtx and leflunomide
both teratogenic, myelosuppression, may cause alopecia, increase transaminases (so need to monitor liver)
38
Monitoring of Leflunomide
FBC LFT (ALT, AST, Albumin, Bilirubin)
39
Which csDMARD can or cannot use with increased transaminase
Methotrexate: can use, 3x ULN just use 75% of dose Leflunomide: cannot use, ALT 2x ULN
40
What is the general MOA of bDMARD and tsDMARD
bDMARD are administered via SC injection or IV infusion Bind to cytokine or receptors to downregulate their functions, which reduces immune and inflammatory responses tsDMARD are administered orally Bind to JAK proteins inside cells to prevent JAK from transphosphorylating the associated cytokine and growth factor receptor
41
What are the bDMARDs
TNF-a (IAGE) Infliximab Adalimumab Golimumab Etanercept IL6 - Tocilizumab CD20 - Rituximab
42
What are the tsDMARDs
Tofacitinib Baricitinib
43
What needs to be done before initiating ts/bDMARD (3 points)
Pre-treatment screening Start after TB treatment Avoid if have untreated Hep B or C Vaccination before initiation Pneumococcal Influenza Hep B Varicella zoster / Herpes zoster Lab testing CBC with wbc, platelet count LFT (ALT, AST, bilirubin, ALP) Lipid panel SCr
44
When should ts/bDMARD be used
When patient does not achieve remission at 6 months
45
What to look out for for each ts/bDMARD drug class
TNF-A Monitor for anti drug antibodies Avoid in heart failure IL6 inhibitor (Tocilizumab) GI perforation, thrombosis JAK inhibitors Higher risk of MACE GI perforation, thrombosis Malignancy risk
46
Which TNF-a are IV, which are SC
IAGE IG are iv AE are sc
47
What are contraindicated with TNF-a
Live vaccination Hepatitis B heart failure
48
What is Anakinra
IL1 receptor antagonist Protein which blocks IL1 receptor
49
What is the MOA of Tofacitinib
Inhibit Jak 1 - 3 Block cytokine production by blocking JAK/STAT activation of gene transcription
50
Side effect of Tofacitinib (3 points)
Immunosuppression Opportunistic infections Anaemia (jak 2) Hyperlipidemia Increase HDL, LDL, TG
51
Which medications cannot be used together in RA
Glucocorticoids cannot be used together with b/tsDMARD, GC needs to be stopped when b/tsDMARD are started bDMARDs and tsDMARDs should not be used together
52
Why are JAK inhibitors last line?
Risk of MACE, malignancy, GI perforation, thrombotic events
53
Should treatment be stopped after patient achieve remission after 6 months?
No, dont discontinue DMARD abruptly, may result in flare
54
non pharm for RA
Patient education Rest during flares, Exercise (to increase muscle strength) if no flare Do range of motion exercises (similar to frozen shoulder) Do aerobic exercise to reduce fatigue, pain, improve sleep Avoid high intensity weight bearing exercises Diet Overcome anorexia, poor diet Weight management if obese Reduce inflammation eg. fish oil Reduce ASCVD risk